haematology
Blood cancers

Local CAR T-cell manufacture launched

CAR T-cell therapy for Australian patients with haematological malignancies will come without the international air miles as local manufacture ramps up. As of last week, Cell Therapies Pty Ltd is the first TGA-approved commercial manufacturer of tisagenlecleucel (Kymriah) at its facility at Melbourne’s Peter MacCallum Cancer Centre. Australia is one of seven manufacturing sites worldwide ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic